Retrospective study assesses hepatic fat fraction in patients with adrenal adenomas, indicating cortisol excess association.
RATIONALE AND OBJECTIVES: This study aimed to evaluate the relationship between mild autonomous cortisol secretion (MACS) caused by adrenal adenomas and hepatic fat fraction (HFF) measured by dual-echo Dixon chemical shift-encoded MRI (dual-echo CSE-MRI). METHODS: This retrospective study included 151 patients with 169 adrenal adenomas evaluated between November 2023 and November 2025. According to post-1 mg dexamethasone suppression test (DST) cortisol levels, patients were classified as having MACS or non-functioning adrenal incidentalomas (NFAI). HFF was quantitatively assessed using dual-echo CSE-MRI. Clinical, biochemical, and imaging findings were analyzed. Correlation analyses and multivariate regression models were used to identify factors associated with hepatic fat fraction and MACS. RESULTS: Forty-five adrenal adenomas (26.6%) were classified as MACS. HFF was significantly higher in patients with MACS compared with those with NFAI (16.0% ± 13.3% vs. 7.1% ± 7.6%, p < 0.001). HFF showed a significant positive correlation with post-DST cortisol levels (r = 0.316, p < 0.001) and fasting glucose levels (r = 0.312, p < 0.001). In multivariate logistic regression analysis, hepatic fat fraction remained independently associated with MACS (OR: 1.084, p < 0.001). Multivariate linear regression analysis demonstrated that post-DST cortisol levels, fasting glucose levels, and age were independently associated with HFF. CONCLUSION: Hepatic fat fraction measured by dual-echo CSE-MRI is increased in patients with MACS and is associated with cortisol excess.
No takes yet. Share an insight, caveat, or question.
Konukoğlu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: